BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26006172)

  • 1. Urinary tract infection of mice to model human disease: Practicalities, implications and limitations.
    Carey AJ; Tan CK; Ipe DS; Sullivan MJ; Cripps AW; Schembri MA; Ulett GC
    Crit Rev Microbiol; 2016 Sep; 42(5):780-99. PubMed ID: 26006172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.
    Steigedal M; Marstad A; Haug M; Damås JK; Strong RK; Roberts PL; Himpsl SD; Stapleton A; Hooton TM; Mobley HL; Hawn TR; Flo TH
    J Immunol; 2014 Dec; 193(12):6081-9. PubMed ID: 25398327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine bacterial urinary tract infections: new developments in old pathogens.
    Thompson MF; Litster AL; Platell JL; Trott DJ
    Vet J; 2011 Oct; 190(1):22-7. PubMed ID: 21239193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Murine Model for Escherichia coli Urinary Tract Infection.
    Hannan TJ; Hunstad DA
    Methods Mol Biol; 2016; 1333():159-75. PubMed ID: 26468108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections.
    Aguilar-Duran S; Horcajada JP; Sorlí L; Montero M; Salvadó M; Grau S; Gómez J; Knobel H
    J Infect; 2012 May; 64(5):478-83. PubMed ID: 22285591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of Intracellular Bacterial Communities during Experimental Urinary Tract Infection Reveals an Abundant and Viable Bacterial Reservoir.
    Duraiswamy S; Chee JLY; Chen S; Yang E; Lees K; Chen SL
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29378794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract.
    Bergsten G; Wullt B; Svanborg C
    Int J Med Microbiol; 2005 Oct; 295(6-7):487-502. PubMed ID: 16238023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli.
    Rippere-Lampe KE; O'Brien AD; Conran R; Lockman HA
    Infect Immun; 2001 Jun; 69(6):3954-64. PubMed ID: 11349064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.
    Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA
    Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of uropathogenic Escherichia coli outer membrane protein T in pathogenesis of urinary tract infection.
    He XL; Wang Q; Peng L; Qu YR; Puthiyakunnon S; Liu XL; Hui CY; Boddu S; Cao H; Huang SH
    Pathog Dis; 2015 Apr; 73(3):. PubMed ID: 25825479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical implications of bacterial pathogenesis and mucosal immunity in chronic urinary tract infection.
    Chieng CCY; Kong Q; Liou NSY; Khasriya R; Horsley H
    Mucosal Immunol; 2023 Feb; 16(1):61-71. PubMed ID: 36642381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.
    Ozer A; Altuntas CZ; Bicer F; Izgi K; Hultgren SJ; Liu G; Daneshgari F
    Pathog Dis; 2015 Apr; 73(3):. PubMed ID: 25663347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The yin-yang driving urinary tract infection and how proteomics can enhance research, diagnostics, and treatment.
    Floyd KA; Meyer AE; Nelson G; Hadjifrangiskou M
    Proteomics Clin Appl; 2015 Dec; 9(11-12):990-1002. PubMed ID: 26255866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacterial urinary tract infections--what is only an annoyance, when is risk involved?].
    Wagenlehner FM; Naber KG
    Ther Umsch; 2002 Sep; 59(9):464-8. PubMed ID: 12369150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of urinary tract infections : An update].
    Magistro G; Marcon J; Schubert S; Gratzke C; Stief CG
    Urologe A; 2017 Jun; 56(6):720-727. PubMed ID: 28455576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotherapy and pathogenesis of uncomplicated UTI: difficult relationships.
    Moura A; Nicolau A; Hooton T; Azeredo J
    J Appl Microbiol; 2009 Jun; 106(6):1779-91. PubMed ID: 19210569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of urinary tract infections: an update.
    Hooton TM
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():1-7; discussion 63-5. PubMed ID: 11051617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of urinary tract infections with normal female anatomy.
    Finer G; Landau D
    Lancet Infect Dis; 2004 Oct; 4(10):631-5. PubMed ID: 15451491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare emergence of symptoms during long-term asymptomatic Escherichia coli 83972 carriage without an altered virulence factor repertoire.
    Köves B; Salvador E; Grönberg-Hernández J; Zdziarski J; Wullt B; Svanborg C; Dobrindt U
    J Urol; 2014 Feb; 191(2):519-28. PubMed ID: 23911604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.